<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Pharmaceutical Commerce articles</title><description>Pharmaceutical Commerce articles</description><link>https://www.pharmaceuticalcommerce.com/news</link><category>Pharmaceutical Commerce articles</category><copyright>© 2026 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.</copyright><lastBuildDate>Sat, 12 Sep 2026 17:43:15 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.pharmaceuticalcommerce.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Pharmaceutical Commerce articles</title><width>144</width><height>47</height><link>https://www.pharmaceuticalcommerce.com/news</link><url>https://www.pharmaceuticalcommerce.com/logo.webp</url></image><item><title>&lt;![CDATA[Why Your NDC-12 Roadmap Should Start Now]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-your-ndc-12-roadmap-should-start-now</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-your-ndc-12-roadmap-should-start-now</guid><description>&lt;![CDATA[In the final installment of his interview with Pharmaceutical Commerce, Cencora&apos;s Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift to NDC-12.]]&gt;</description><pubDate>Sat, 12 Sep 2026 17:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Gregg Gorniak: What Changed in Five Years of DSCSA?]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/gregg-gorniak-what-changed-in-five-years-of-dscsa-</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/gregg-gorniak-what-changed-in-five-years-of-dscsa-</guid><description>&lt;![CDATA[In the final installment of his interview with Pharmaceutical Commerce, Cencora&apos;s Gregg Gorniak looks back at DSCSA&apos;s five-year evolution and where serialized data is creating value beyond compliance.]]&gt;</description><pubDate>Fri, 11 Sep 2026 15:26:02 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Pharma&apos;s Next AI Challenge Is Supervision, Not Adoption]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-next-ai-challenge-is-supervision-not-adoption</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-next-ai-challenge-is-supervision-not-adoption</guid><description>&lt;![CDATA[Authenticx CEO Amy Brown on why patient support AI needs continuous oversight, not just adoption.]]&gt;</description><pubDate>Fri, 11 Sep 2026 13:28:11 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Kala Shankle on What Comes Next for National Licensure]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/kala-shankle-on-what-comes-next-for-national-licensure</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/kala-shankle-on-what-comes-next-for-national-licensure</guid><description>&lt;![CDATA[HDA&apos;s Kala Shankle unpacks the biggest open question on preemption and offers a two-step playbook for wholesalers and 3PLs preparing for national licensure.]]&gt;</description><pubDate>Thu, 10 Sep 2026 15:07:27 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: DHL&apos;s New Singapore Hub and Pharma Rethinks Go-To Market ]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-dhl-s-new-singapore-hub-and-pharma-rethinks-go-to-market</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-dhl-s-new-singapore-hub-and-pharma-rethinks-go-to-market</guid><description>&lt;![CDATA[In this week&apos;s Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore&apos;s Changi Airport, a new report finds pharma&apos;s commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.]]&gt;</description><pubDate>Thu, 10 Sep 2026 12:04:19 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/faq-inside-the-latest-mfn-deals-signed-by-nine-drugmakers</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/faq-inside-the-latest-mfn-deals-signed-by-nine-drugmakers</guid><description>&lt;![CDATA[Twenty-six manufacturers now hold most-favored-nation agreements, and the commitments attached to the pricing terms may matter more than the prices themselves.]]&gt;</description><pubDate>Wed, 09 Sep 2026 15:24:48 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why the Biggest NDC-12 Risk Sits in the Handoffs]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-the-biggest-ndc-12-risk-sits-in-the-handoffs</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-the-biggest-ndc-12-risk-sits-in-the-handoffs</guid><description>&lt;![CDATA[Cardinal Health&apos;s Liberty Dewey outlines the four parallel work streams driving the NDC-12 transition, and why the biggest risk sits in trading partner handoffs rather than any single system.]]&gt;</description><pubDate>Wed, 09 Sep 2026 13:57:16 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[The Transition to Home: Why Confidence is Critical to Patient Success]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/the-transition-to-home-why-confidence-is-critical-to-patient-success</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/the-transition-to-home-why-confidence-is-critical-to-patient-success</guid><description>&lt;![CDATA[Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient&apos;s home.]]&gt;</description><pubDate>Wed, 09 Sep 2026 13:42:22 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Account Teams Call ClaimGuardRx Their Smartest Teammate]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/account-teams-call-claimguardrx-their-smartest-teammate</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/account-teams-call-claimguardrx-their-smartest-teammate</guid><description>&lt;![CDATA[Logan Melchione shares how ClaimGuardRx gives account teams a fast, conversational way to tackle diversion and fraud together, and what that means for clients and patients.]]&gt;</description><pubDate>Wed, 09 Sep 2026 13:26:02 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[The Proprietary LLM Behind ClaimGuardRx&apos;s Detect-and-Respond Engine]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/proprietary-llm-claimguardrx-detect-respond-engine</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/proprietary-llm-claimguardrx-detect-respond-engine</guid><description>&lt;![CDATA[Bryan Dennison breaks down the purpose-built technology behind ClaimGuardRx and how its detect-and-respond design keeps manufacturers ahead of evolving diversion tactics.]]&gt;</description><pubDate>Wed, 09 Sep 2026 13:04:48 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[ClaimGuardRx Shapes How Programs are Designed, Priced, and Optimized From the Start]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/claimguardrx-designed-priced-optimized-from-start</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/claimguardrx-designed-priced-optimized-from-start</guid><description>&lt;![CDATA[Matt Turner shares how ClaimGuardRx is redefining patient affordability by turning claims data into a proactive defense against maximizers and accumulators.]]&gt;</description><pubDate>Wed, 09 Sep 2026 13:04:11 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/how-the-rising-risk-of-cargo-theft-is-creating-new-urgency-across-pharma-supply-chains</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/how-the-rising-risk-of-cargo-theft-is-creating-new-urgency-across-pharma-supply-chains</guid><description>&lt;![CDATA[Overhaul&apos;s Danny Ramon argues that quality and regulatory teams, not just logistics, need faster protocols and more accessible stability data, since stolen or compromised product that re-enters the supply chain through gray markets can ultimately reach patients.]]&gt;</description><pubDate>Tue, 08 Sep 2026 17:06:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Ameer Ali on Why NDC-12 Readiness Can&apos;t Wait]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/ameer-ali-on-why-ndc-12-readiness-can-t-wait</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/ameer-ali-on-why-ndc-12-readiness-can-t-wait</guid><description>&lt;![CDATA[Cencora&apos;s Ameer Ali explains why trading partners&apos; systems, not the NDC-12 deadline itself, determine whether product keeps moving through the supply chain during the transition.]]&gt;</description><pubDate>Tue, 08 Sep 2026 15:31:07 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[A Complex Chess Game With Invisible Chess Pieces]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/a-complex-chess-game-with-invisible-chess-pieces</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/a-complex-chess-game-with-invisible-chess-pieces</guid><description>&lt;![CDATA[Ed Schoonveld examines the uncertainty surrounding President Trump&apos;s MFN drug pricing agreements, stalled GENEROUS, GLOBE and GUARD proposals, and their ripple effects on ex-US drug launches.]]&gt;</description><pubDate>Tue, 08 Sep 2026 14:34:01 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Using AI to Manage GDP-Compliant Supply Chains]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/using-ai-to-manage-gdp-compliant-supply-chains</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/using-ai-to-manage-gdp-compliant-supply-chains</guid><description>&lt;![CDATA[AI-native operating systems present new capabilities to improve pharma supply chain operations.]]&gt;</description><pubDate>Tue, 08 Sep 2026 14:05:13 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Gregg Gorniak on Turning DSCSA Compliance Investment Into Shared Value]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/gregg-gorniak-on-turning-dscsa-compliance-into-shared-value</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/gregg-gorniak-on-turning-dscsa-compliance-into-shared-value</guid><description>&lt;![CDATA[Cencora&apos;s Gregg Gorniak on where DSCSA trading partners find shared value in compliance investment, and where that alignment breaks down.]]&gt;</description><pubDate>Tue, 08 Sep 2026 13:32:35 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: MFN Expansion, GoodRx&apos;s Family Plan, CSafe&apos;s Reusable Cover]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-mfn-expansion-goodrx-s-family-plan-csafe-s-reusable-cover</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-mfn-expansion-goodrx-s-family-plan-csafe-s-reusable-cover</guid><description>&lt;![CDATA[In this week&apos;s Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.]]&gt;</description><pubDate>Fri, 04 Sep 2026 14:30:17 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Q&amp;A: McKesson&apos;s Scott Mooney on Closing DSCSA Data Exchange Gaps ]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/q-a-mckesson-s-scott-mooney-on-closing-dscsa-data-exchange-gaps</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/q-a-mckesson-s-scott-mooney-on-closing-dscsa-data-exchange-gaps</guid><description>&lt;![CDATA[McKesson&apos;s Scott Mooney discusses the technical and operational challenges of DSCSA compliance, from linking ERP systems to EPCIS to recurring friction in 340B transaction data exchange.]]&gt;</description><pubDate>Fri, 04 Sep 2026 13:21:22 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Kala Shankle on States, Timing and National Licensure Readiness]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/kala-shankle-on-states-timing-and-national-licensure-readiness</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/kala-shankle-on-states-timing-and-national-licensure-readiness</guid><description>&lt;![CDATA[HDA&apos;s Kala Shankle says a two-year national licensure runway for distributors could work, but only if states, the FDA and industry move in parallel.]]&gt;</description><pubDate>Thu, 03 Sep 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[When Payers Know the Price of Everything]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/when-payers-know-the-price-of-everything</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/when-payers-know-the-price-of-everything</guid><description>&lt;![CDATA[Pharmacy directors are using the growing number of publicly visible drug prices as leverage, new research shows. Manufacturers need to be ready, before those prices become a negotiation tool.]]&gt;</description><pubDate>Wed, 02 Sep 2026 15:30:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[What the Independent Pharmacy Cooperative Acquisition of USave Pharmacy Group Signals]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/ipc-acquires-usave-pharmacy-group</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/ipc-acquires-usave-pharmacy-group</guid><description>&lt;![CDATA[The acquisition formalizes a nearly decade-old partnership as independent pharmacies lean on cooperatives to offset PBM reimbursement pressure and closures.]]&gt;</description><pubDate>Wed, 02 Sep 2026 14:41:59 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Inside the Three-Year Transition to NDC-12]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/inside-the-three-year-transition-to-ndc-12</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/inside-the-three-year-transition-to-ndc-12</guid><description>&lt;![CDATA[Cardinal Health&apos;s Liberty Dewey breaks down the NDC-12 transition timeline and the vendor, association and wholesaler support smaller pharmacies will need to get ready.]]&gt;</description><pubDate>Wed, 02 Sep 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks ]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/beyond-the-patent-cliff-why-generics-and-biosimilars-demand-different-playbooks</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/beyond-the-patent-cliff-why-generics-and-biosimilars-demand-different-playbooks</guid><description>&lt;![CDATA[As loss-of-exclusivity events accelerate, generics and biosimilars are diverging into distinct business models, demanding different regulatory, IP, and market access strategies from manufacturers.]]&gt;</description><pubDate>Tue, 01 Sep 2026 15:30:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[The Difference Between Meeting DSCSA and Mastering It]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/the-difference-between-meeting-dscsa-and-mastering-it</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/the-difference-between-meeting-dscsa-and-mastering-it</guid><description>&lt;![CDATA[Cencora&apos;s Gregg Gorniak breaks down what separates basic DSCSA compliance from using it to streamline transactions and strengthen trading partnerships.]]&gt;</description><pubDate>Tue, 01 Sep 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/mfn-program-nine-drugmakers-manufacturing-investment</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/mfn-program-nine-drugmakers-manufacturing-investment</guid><description>&lt;![CDATA[Nine more manufacturers join the MFN program, pairing new Medicaid pricing deals with $19.6B in U.S. manufacturing investment and API reserve donations.]]&gt;</description><pubDate>Mon, 31 Aug 2026 20:53:58 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Cencora&apos;s Ameer Ali on Readying Systems for NDC-12]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/hda-2026-cencora-s-ameer-ali-on-readying-systems-for-ndc-12</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/hda-2026-cencora-s-ameer-ali-on-readying-systems-for-ndc-12</guid><description>&lt;![CDATA[Cencora&apos;s Ameer Ali explains how the shift to NDC-12 is reshaping supply chain systems and why readiness still varies widely across manufacturers.]]&gt;</description><pubDate>Mon, 31 Aug 2026 15:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[What National Licensure Means for Wholesalers and 3PLs]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/hda-2026-what-national-licensure-means-for-distributors</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/hda-2026-what-national-licensure-means-for-distributors</guid><description>&lt;![CDATA[HDA&apos;s Kala Shankle explains what a national licensure standard could mean for wholesale distributors and 3PLs, and why its success depends on how much state-level variation remains.]]&gt;</description><pubDate>Mon, 31 Aug 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[The Evolving Role of RWD and AI-Driven Insights In Pharma Strategy]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/the-evolving-role-of-rwd-and-ai-driven-insights-in-pharma-strategy</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/the-evolving-role-of-rwd-and-ai-driven-insights-in-pharma-strategy</guid><description>&lt;![CDATA[Alexis Cogswell of Inizio Medical explains how combining real-world data, AI analysis and HCP context is helping medical affairs teams move from retrospective reporting to actionable, real-time strategy.]]&gt;</description><pubDate>Fri, 28 Aug 2026 15:15:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Cencora&apos;s Gregg Gorniak on Using AI to Get Ahead of DSCSA Data Gaps]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/cencoras-gregg-gorniak-on-using-ai-to-get-ahead-of-dscsa-data-gaps</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/cencoras-gregg-gorniak-on-using-ai-to-get-ahead-of-dscsa-data-gaps</guid><description>&lt;![CDATA[Ahead of HDA&apos;s 2026 Traceability Seminar, Cencora&apos;s Gregg Gorniak explains how AI and RFID are being used to catch DSCSA data gaps before trucks reach the dock.]]&gt;</description><pubDate>Fri, 28 Aug 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: Medicaid Deals, GLP-1 Pullback, McKesson&apos;s Buy]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-medicaid-deals-glp-1-pullback-mckessons-buy</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-medicaid-deals-glp-1-pullback-mckessons-buy</guid><description>&lt;![CDATA[In this week&apos;s Pharma Pulse, new Medicaid pricing deals are rumored, employer GLP-1 pullback, and McKesson&apos;s $2.25B oncology buy.]]&gt;</description><pubDate>Thu, 27 Aug 2026 13:45:12 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item></channel></rss>